SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-003997
Filing Date
2012-01-06
Accepted
2012-01-05 21:09:16
Documents
4
Period of Report
2012-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d277923d8k.htm 8-K 26810
2 INDENTURE d277923dex41.htm EX-4.1 505477
3 PRESS RELEASE d277923dex991.htm EX-99.1 7365
4 GRAPHIC g277923g18x86.jpg GRAPHIC 7894
  Complete submission text file 0001193125-12-003997.txt   552118
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 12513020
SIC: 2836 Biological Products, (No Diagnostic Substances)